Overall rank by patents
#16,215
of 50,000 tracked assignees
USPTO PatentsView assignee record - 18 granted patents across 7 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY).
The verdict
According to USPTO PatentsView, Nalu ranks #16,215 of 50,000 tracked US assignees by granted-patent volume, with 18 patents across 7 technology areas.
USPTO PatentsView assignee plate
Corpus R16215 · US Corporation #16,215 · 18 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Nanjing Hydraulic Research Institute (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Nalu Medical · this assignee
40 score
3D Lighting Innovati… · lowest
7 score
What this shows Nalu Medical, Inc. stamps GRANTS-MICRO, MID-PACK, PHOTO-FINISH, CPC-NARROW, INNOV-PAR, CLAIMS-DENSE, TYPE-USCORP, VEL-SURGE, BOOK-FULL. Volume places it #16,215 of 50,000; Innovation Score 40.4/100 sits in the top 36% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Nanjing Hydraulic Research Institute (±0 grants).
Nalu Medical, Inc. has been granted 18 US utility patents between 2019 and 2025, placing Nalu Medical, Inc. at #16,215 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 7 distinct Cooperative Patent Classification (CPC) subclasses, averaging 28.3 claims per patent with primary concentration in A61N (ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY). As a US Corporation, Nalu Medical, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Nalu sits between Novelmed Therapeutics, Inc (18 patents, rank #16,225) and National Gypsum Properties, Llc (18 patents, rank #16,233) - the closest US assignees by grant volume. The composite Innovation Score of 40.4/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 13 grants, compared with 2 in the 2015–2019 window, a +550% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.
Claim depth and technology breadth describe this aggregate record. Nalu Medical, Inc.'s 28.3 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 7 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
NOVELMED THERAPEUTICS, INC
18 patents
NURALOGIX CORPORATION
18 patents
NUVATION BIO INC.
18 patents
NYX, Inc.
18 patents
Nanjing Hydraulic Research Institute
18 patents
Nanofiber Solutions LLC
18 patents
NantMobility, LLC
18 patents
National Gypsum Properties, LLC
18 patents
Nalu Medical, Inc.
18 patents
What this shows Nalu holds 18 patents at rank #16,229, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #16,229 in granted patent volume.
Other assignees with the most granted patents in Nalu's primary technology class.
Nalu's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 36% higher than 64% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 2 | 11.1% |
| 2020 | 1 | 5.6% |
| 2021 | 5 | 27.8% |
| 2022 | 3 | 16.7% |
| 2023 | 3 | 16.7% |
| 2024 | 1 | 5.6% |
| 2025partial year | 3 | 16.7% |
Top 7 of 7 technology areas
Overall rank by patents
#16,215
of 50,000 tracked assignees
40.4 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.